
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study
Yaroslav Winter, Raya Abou Dargham, Susana Patiño Tobón, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 733-742
Open Access | Times Cited: 8
Yaroslav Winter, Raya Abou Dargham, Susana Patiño Tobón, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 733-742
Open Access | Times Cited: 8
Showing 8 citing articles:
Post-marketing Experience with Cenobamate in the Treatment of Focal Epilepsies: A Multicentre Cohort Study
Adam Strzelczyk, Felix von Podewils, Hajo M. Hamer, et al.
CNS Drugs (2025)
Open Access
Adam Strzelczyk, Felix von Podewils, Hajo M. Hamer, et al.
CNS Drugs (2025)
Open Access
Effectiveness and safety of adjunctive cenobamate in people with focal‐onset epilepsy: Interim results after 24‐week observational period from the BLESS study
Simona Lattanzi, Fedele Dono, G. D’Orsi, et al.
Epilepsia (2025)
Open Access
Simona Lattanzi, Fedele Dono, G. D’Orsi, et al.
Epilepsia (2025)
Open Access
Cenobamate add-on therapy for drug-resistant focal seizures: a systematic review and meta-analysis
Felipe Alves de Paiva, Artur Menegaz de Almeida, Aminah Abrão Fauaz Ritter Lima, et al.
Expert Review of Neurotherapeutics (2025), pp. 1-7
Closed Access
Felipe Alves de Paiva, Artur Menegaz de Almeida, Aminah Abrão Fauaz Ritter Lima, et al.
Expert Review of Neurotherapeutics (2025), pp. 1-7
Closed Access
Recent Advances in Pharmacologic Treatments of Drug-Resistant Epilepsy: Breakthrough in Sight
Pavel Klein, Daniel Friedman, Patrick Kwan
CNS Drugs (2024) Vol. 38, Iss. 12, pp. 949-960
Closed Access | Times Cited: 4
Pavel Klein, Daniel Friedman, Patrick Kwan
CNS Drugs (2024) Vol. 38, Iss. 12, pp. 949-960
Closed Access | Times Cited: 4
Real‐world use of cenobamate in adults: Efficacy and predictors of treatment response
Itai Loushy, Lilach Goldstein, Kathryn N. Devlin, et al.
Epilepsia (2025)
Closed Access
Itai Loushy, Lilach Goldstein, Kathryn N. Devlin, et al.
Epilepsia (2025)
Closed Access
Neurotoxicity study of cenobamate-induced zebrafish early developmental stages
Jiahao Liu, Liya Fang, Chao Gong, et al.
Toxicology and Applied Pharmacology (2024) Vol. 495, pp. 117201-117201
Closed Access
Jiahao Liu, Liya Fang, Chao Gong, et al.
Toxicology and Applied Pharmacology (2024) Vol. 495, pp. 117201-117201
Closed Access
Impact of lifetime antiepileptic drug history on cenobamate efficacy in adults with focal epilepsy
Eva Martinez‐Lizana, Armin Brandt, Yulia Novitskaya, et al.
Seizure (2024) Vol. 125, pp. 94-98
Open Access
Eva Martinez‐Lizana, Armin Brandt, Yulia Novitskaya, et al.
Seizure (2024) Vol. 125, pp. 94-98
Open Access